甘利欣治疗肝炎病毒性传染病患者的临床效果
Clinical effect of ganlixin in treating hepatitis patients with viral infectious diseases
李芳芳 1朱坚胜1
作者信息
- 1. 温州医科大学附属台州医院 感染科,浙江 台州 317000
- 折叠
摘要
目的 探究肝炎病毒性传染病患者接受甘利欣治疗的价值.方法 选取肝炎病毒性传染病患者100例作为此次研究对象,所选时间为2015年2月~2016年2月,按照其治疗方案的差异分为对照组和实验组,每组50例,其中对照组接受常规方式治疗,实验组同时接受甘利欣治疗,对比2组肝炎病毒性传染病患者治疗结果的差异性.结果 实验组肝炎病毒性传染病患者的总有效率(94.00%)明显优于对照组的总有效率(74.00%)(P<0.05);2组不良反应率对比,差异无统计学意义;实验组治疗后的肝功能指标水平优于对照组(P<0.05).结论 肝炎病毒性传染病患者接受甘利欣治疗,可提高治疗的疗效,改善肝功能指标,且安全性较高.
Abstract
Objective To explore the value of ganlixin in the treatment of patients with hepatitis viral infectious diseases. Methods 100 cases of hepatitis viral infectious disease patients were selected as the research objects from February 2015 to February 2016, according to the differences of treatment, patients were divided into the experiment group and the control group, the control group was treated with routine treatment, the experimental group was treated with glycyrrhizic acid, the results of the treatment of patients with hepatitis viral infections in two groups were compared. Results The total effective rate in the experimental group (94.00%) was significantly better than that (74.00%) in the control group (P<0.05). There was no statistical significance in adverse reactions between 2 groups. The hepatic functional index of the experimental group was better than that of the control group (P<0.05). Conclusion The treatment of hepatitis patients with viral infectious diseases could improve the curative effect of treatment and liver function index with high safety and significance.
关键词
甘利欣/肝炎病毒性传染病/治疗价值Key words
ganlixin/viral infectious diseases of hepatitis/therapeutic value引用本文复制引用
出版年
2017
NETL
NSTL
维普
万方数据